FOXO1, short for Forkhead box protein O1, is an intricately regulated transcription factor with a pivotal role in the orchestration of cellular responses to a variety of stimuli. It is a member of the O class of forkhead box transcription factors, recognized by a conserved winged-helix DNA-binding domain. FOXO1's involvement spans several cellular processes, including glucose metabolism, oxidative stress response, cell cycle regulation, and apoptosis. It is a substrate for several kinases, including AKT, SGK, and IKK, which regulate its activity through phosphorylation. This post-translational modification typically results in the sequestration of FOXO1 in the cytoplasm, inhibiting its transcriptional activity. Conversely, dephosphorylation of FOXO1 leads to its translocation into the nucleus, where it can activate the transcription of genes responsible for various cellular functions. The precise regulation of FOXO1 is thus critical to maintaining cellular homeostasis and responding to environmental changes.
A range of chemical compounds has been identified that can potentially induce the expression of FOXO1. These activators interact with cellular signaling pathways, often leading to changes in the phosphorylation status of FOXO1 and its subsequent activation. For instance, compounds like resveratrol and metformin are known to exert influence on the cellular energy-sensing pathways, which include AMP-activated protein kinase (AMPK) and sirtuins. By modulating these pathways, such compounds can promote the dephosphorylation and nuclear localization of FOXO1, thereby enhancing its transcriptional activity. Similarly, polyphenols like quercetin and epigallocatechin gallate may engage with signaling cascades linked to oxidative stress, potentially leading to an upsurge in FOXO1 expression. Other compounds such as lithium chloride, which inhibits GSK-3, and sodium butyrate, a histone deacetylase inhibitor, can also contribute to changes in the expression and activity of FOXO1 by altering its phosphorylation state or facilitating the transcriptional machinery's access to the FOXO1 promoter, respectively. These interactions underscore the complexity of cellular regulation and highlight the diverse mechanisms through which FOXO1 expression can be modulated by various molecules within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol may upregulate FOXO1 by activating sirtuin enzymes, which can lead to the deacetylation and transcriptional enhancement of FOXO1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has the potential to stimulate FOXO1 expression by neutralizing oxidative agents, thereby preserving FOXO1's transcriptional activity. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin can increase FOXO1 expression through the activation of AMP-activated protein kinase, which enhances FOXO1's nuclear localization and transcriptional function. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin may stimulate FOXO1 expression by serving as a co-factor for transcriptional enzymes that target FOXO1 gene promoters. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate can increase FOXO1 expression by reducing oxidative damage within cells, which would otherwise degrade FOXO1 mRNA or hinder its gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could induce FOXO1 expression by inhibiting GSK-3, leading to reduced phosphorylation of FOXO1 and its subsequent stabilization and accumulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate may elevate FOXO1 expression by hyperacetylating histones around the FOXO1 promoter, improving the accessibility of the transcriptional machinery. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might upregulate FOXO1 expression by binding to retinoic acid receptors, which then interact with FOXO1 gene enhancer elements. | ||||||
3,3′-Diindolylmethane | 1968-05-4 | sc-204624 sc-204624A sc-204624B sc-204624C sc-204624D sc-204624E | 100 mg 500 mg 5 g 10 g 50 g 1 g | $36.00 $64.00 $87.00 $413.00 $668.00 $65.00 | 8 | |
3,3'-Diindolylmethane could induce FOXO1 expression by stimulating detoxification pathways that converge on the FOXO1 gene, leading to its transcriptional activation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
DL-Sulforaphane may upregulate FOXO1 by activating the Nrf2 detoxification pathway, which includes the transcriptional activation of FOXO1 as part of its cellular defense mechanism. |